Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Neoplasms

Clinical trial condition

Esophageal Neoplasms

Explore clinical trials studying Esophageal Neoplasms. Study availability and eligibility vary by location and protocol.

1,231 public trials 309 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Neoplasms trial results

Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT06239194

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +74 more
Locations: Sarah Cannon Research Institute Denver, Colorado, United States

Sylvester Comprehensive Cancer Center - University of Miami Health System Miami, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

View Trial Details

Recruiting

CPAP or BiPAP for Motion Mitigation During Radiotherapy

NCT04986293

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +19 more
Locations: University Medical Center Groningen Groningen, Provincie Groningen, Netherlands

View Trial Details

Recruiting

High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients

NCT07307560

Conditions: Apnea, Digestive System Diseases, Digestive System Neoplasms, +26 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

The First Hospital Of Jiaxing Jiaxing, Zhejiang, China

Quzhou People's Hospital Quzhou, Zhejiang, China

View Trial Details

Recruiting

Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers

NCT02838836

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +38 more
Locations: Ellis Fischel Cancer Center, University of Missouri Columbia, Missouri, United States

View Trial Details

Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

NCT05297734

Conditions: Adenocarcinoma, Adnexal Diseases, Astrocytoma, +81 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Mobile, Alabama, United States

Beckman Research Institute of City of Hope Duarte, California, United States

VA Medical Center, Fresno Fresno, California, United States

View all 17 locations

View Trial Details

Recruiting

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

NCT05357846

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +15 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

NCT06440174

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Cwm Taf UHB Abercynon, United Kingdom

Royal Bournemouth Hospital Bournemouth, United Kingdom

Cambridge University NHS Foundation Trust Cambridge, United Kingdom

Cardiff and Vale UHB Cardiff, United Kingdom

View all 14 locations

View Trial Details

Recruiting

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

NCT05187182

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +13 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer

NCT06713993

Conditions: Atrophy, Cardiovascular Abnormalities, Cardiovascular Diseases, +27 more
Locations: Semmelweis University Budapest, Hungary

View Trial Details

Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions: Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations: City of Hope Duarte, California, United States

UC IRVINE Health Orange, California, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

Stanford Cancer Institute Stanford, California, United States

View all 53 locations

View Trial Details